Xanax XR Recall: What You Necessitate to Know About the Nationwide Drug Recall
A specific lot of the widely prescribed anti-anxiety medication Xanax XR has been recalled nationwide after failing quality control tests related to how the medication dissolves in the body, according to the U.S. Food and Drug Administration.
The recall, initiated by Viatris Specialty LLC, affects 3-milligram tablets of Xanax XR sold in 60-tablet bottles. The affected lot was manufactured in Ireland and distributed between August 27, 2024, and May 29, 2025.
Why Was Xanax XR Recalled?
The FDA announced the recall after laboratory testing revealed that the affected tablets failed dissolution specifications. Dissolution tests measure how quickly a drug breaks down and releases its active ingredient after ingestion. When a medication fails these tests, it may not deliver the intended dose consistently, potentially affecting its effectiveness.
The recall notice states that the failure was due to “out-of-specification dissolution results,” meaning the tablets did not dissolve at the proper rate to ensure reliable drug delivery.
Which Lots Are Affected?
The recall applies specifically to Xanax XR 3mg tablets with:
- Lot number: 8177156
- Expiration date: February 28, 2027
These bottles were distributed nationwide during the specified timeframe. Patients are advised to check their medication packaging for this lot number and expiration date.
What Is the Risk Level of This Recall?
The FDA has classified this as a Class II recall. According to the agency, a Class II recall indicates a situation where employ of or exposure to the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This classification reflects that while the defective medication poses a concern, the likelihood of severe harm is considered low.
What Should Patients Do?
Anyone who has the affected Xanax XR tablets should:
- Stop taking the medication immediately
- Contact their healthcare provider or pharmacist for guidance
- Follow proper disposal procedures for unused medication
- Not abruptly discontinue use without medical supervision, as sudden cessation of benzodiazepines can lead to withdrawal symptoms
Patients should not dispose of medication by flushing it down the toilet or pouring it into a drain unless specifically instructed to do so. Instead, they should consult local waste management authorities or pharmacy take-back programs.
About Xanax XR
Xanax XR (alprazolam extended-release) is a benzodiazepine medication prescribed for the treatment of panic disorder, with or without agoraphobia, in adults. It is designed to release the active ingredient slowly over time to maintain steady blood levels and reduce the frequency of dosing.
The medication works by enhancing the effects of gamma-aminobutyric acid (GABA), a natural chemical in the body that helps calm nerve activity in the brain.
Staying Informed About Medication Recalls
Drug recalls, while uncommon, are an important part of the pharmaceutical safety system. They are typically initiated voluntarily by manufacturers in coordination with regulatory agencies like the FDA when quality issues are identified.
Patients can stay informed about medication recalls by:
- Checking the FDA’s official website for recall notices
- Signing up for email alerts from the FDA or their pharmacy
- Discussing any concerns with their healthcare provider
It is essential never to stop or change any prescription medication without first consulting a qualified medical professional.
This article is based on information from the U.S. Food and Drug Administration and official recall notices. For the most current details, refer to the FDA’s MedWatch program or contact your healthcare provider.